NCT06191874

Brief Summary

The objective of this project is to evaluate next generation visualization tools and surgical targeting models for clinical deep brain stimulation (DBS). This study will evaluate the performance of HoloDBS software in comparison to the current standard (SOC) clinical planning tools to prepare for DBS surgery. The investigators hypothesize that HoloDBS will provide more detailed and anatomically useful information to the neurosurgeon and neurologist than the current clinical standard. The study team reviews electronic medical records (EMR) from patients who are undergoing DBS surgery. There are no study visits involved in this study as only data from standard clinical care will be used. All study activities are executed by the study team and there are no interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2025

Completed
Last Updated

October 24, 2025

Status Verified

February 1, 2025

Enrollment Period

1.2 years

First QC Date

December 6, 2023

Last Update Submit

October 22, 2025

Conditions

Keywords

DBSParkinson's Disease

Outcome Measures

Primary Outcomes (1)

  • Difference between the actual post-operative location of the DBS electrode and the planned location.

    Comparison of the post-operative position of the DBS electrode to the location that was defined in the standard-of-care plan and the HoloDBS plan.

    1 month after surgery

Secondary Outcomes (1)

  • Number of physicians who reply 'yes' to the question, 'Was the additional data available in the HoloDBS application valuable in defining your theoretical optimal electrode position?'

    6 months and 1 year after study starts

Study Arms (2)

Surgery planning by SOC methods, then by HoloDBS

Standard-of-care (SOC) surgery plan is built before the HoloDBS hypothetical surgery plan

Other: Standard-of-care (SOC) surgery planOther: HoloDBS hypothetical surgery plan

Surgery planning by HoloDBS, then by SOC methods

HoloDBS hypothetical surgery plan is built before the standard-of-care (SOC) surgery plan

Other: Standard-of-care (SOC) surgery planOther: HoloDBS hypothetical surgery plan

Interventions

Use of SOC clinical planning tools to prepare for DBS (deep brain stimulation) surgery

Surgery planning by HoloDBS, then by SOC methodsSurgery planning by SOC methods, then by HoloDBS

Use of next generation visualization tools and surgical targeting models to hypothetically prepare for DBS (deep brain stimulation) surgery

Surgery planning by HoloDBS, then by SOC methodsSurgery planning by SOC methods, then by HoloDBS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with Parkinson's disease scheduled for Deep Brain Stimulation Surgery

You may not qualify if:

  • age 18 years and over
  • meeting qualification for deep brain stimulation for Parkinson's disease with one or more of medication refractory tremor, motor fluctuations despite medication optimization, or levodopa responsiveness but limited by medication induced adverse effects (nausea, dystonia, dyskinesia for example).
  • consideration of alternate diagnosis to Parkinson disease
  • high risk medical comorbidities which would make the patient not a candidate for surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University

Durham, North Carolina, 27708, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2023

First Posted

January 5, 2024

Study Start

March 1, 2024

Primary Completion

May 29, 2025

Study Completion

May 29, 2025

Last Updated

October 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations